LOINC
Version 2.71

35086-8Second trimester triple maternal screen panel - Serum or PlasmaActive

Term Description

Triple marker screening is performed at 16-18 weeks' gestation for determining fetal anomalities including Trisomy 18, Trisomy 21 (Down's syndrome) and Neural Tube Defects (NTD).
Source: Regenstrief LOINC

Panel Hierarchy
Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
35086-8 Second trimester triple maternal screen panel - Serum or Plasma
Indent49087-0 Maternal screen clinical predictors panel
IndentIndent30525-0 Age R-a a
IndentIndent43993-5 Age at delivery O a
IndentIndent11778-8 Delivery date Estimated O
IndentIndent11977-6 [#] Parity O {#}
IndentIndent11996-6 [#] Pregnancies O {#}
IndentIndent21484-1 Mother's race O
IndentIndent21112-8 Birth date O {mm/dd/yyyy}
IndentIndent29463-7 Body weight O [lb_av];kg
IndentIndent32624-9 Race O
IndentIndent18185-9 Gestational age O wk
IndentIndent21299-3 Gestational age method O
IndentIndent11878-6 Number of fetuses by US O {#}
IndentIndent8665-2 Last menstrual period start date O {date}
IndentIndent34970-4 Ultrasound date O
IndentIndent33248-6 Diabetes status [Identifier] O
IndentIndent44877-9 Insulin dependent diabetes mellitus [Presence] O
IndentIndent49053-2 History of Neural tube defect Narrative O
IndentIndent68327-6 Egg donor age a
IndentIndent68328-4 Previous fetus defect
Indent1834-1 Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma O ng/mL
Indent20450-3 Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma R {M.o.M}
Indent49585-3 Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma O {M.o.M}
Indent23811-3 Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma O {M.o.M}
Indent32166-1 Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma O {M.o.M}
Indent43998-4 Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes in Serum or Plasma O {M.o.M}
Indent43996-8 Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes+weight in Serum or Plasma O {M.o.M}
Indent21264-7 Estriol (E3).unconjugated [Multiple of the median] adjusted in Serum or Plasma O {M.o.M}
Indent21265-4 Estriol (E3).unconjugated [Multiple of the median] unadjusted in Serum or Plasma O {M.o.M}
Indent50610-5 Alpha-1-Fetoprotein [Multiple of the median] adjusted for multiple gestations in Serum or Plasma O {M.o.M}
Indent43997-6 Alpha-1-Fetoprotein [Multiple of the median] adjusted for weight in Serum or Plasma O {M.o.M}
Indent23812-1 Alpha-1-Fetoprotein [Multiple of the median] unadjusted in Serum or Plasma O {M.o.M}
Indent19080-1 Choriogonadotropin [Units/volume] in Serum or Plasma O m[IU]/mL
Indent20465-1 Choriogonadotropin [Multiple of the median] in Serum or Plasma R {M.o.M}
Indent45371-2 Multiple pregnancy
Indent2250-9 Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma O ng/mL
Indent20466-9 Estriol (E3).unconjugated [Multiple of the median] in Serum or Plasma R {M.o.M}
Indent49838-6 Neural tube defect risk [Likelihood] in Population {risk}
Indent48803-1 Neural tube defect risk [Likelihood] in Fetus R %
Indent43995-0 Trisomy 21 risk [Likelihood] in Fetus R {risk}
Indent49583-8 Trisomy 21 risk cutoff in Fetus O
Indent49090-4 Fetal Trisomy 21 risk [Likelihood] Based on maternal age O {risk}
Indent43994-3 Trisomy 18 risk [Likelihood] in Fetus R {risk}
Indent47222-5 Trisomy 21 risk based on maternal age+Alpha-1-Fetoprotein+Choriogonadotropin+Estriol.unconjugated [Likelihood] in Fetus
Indent47223-3 Fetal Trisomy 18 risk [Likelihood] Based on maternal age O {risk}
Indent49582-0 Trisomy 18 risk cutoff in Fetus O
Indent49572-1 Second trimester triple maternal screen [Interpretation] in Serum or Plasma Narrative O

Fully-Specified Name

Component
Second trimester triple maternal screen panel
Property
-
Time
Pt
System
Ser/Plas
Scale
-
Method

Additional Names

Short Name
2nd trimester 3 screen Pnl SerPl
Display Name
Second trimester triple maternal screen panel
Consumer Name Alpha
Second trimester triple maternal screen panel, Blood

Basic Attributes

Class
PANEL.CHEM
Type
Laboratory
First Released
Version 2.11
Last Updated
Version 2.42
Order vs. Observation
Order
Panel Type
Panel

Language Variants Get Info

zh-CNChinese (China)
中期妊娠孕妇三项筛查组套:-:时间点:血清/血浆:-:
nl-NLDutch (Netherlands)
tweede trimester triple maternale screening panel:-:moment:serum of plasma:-:
et-EEEstonian (Estonia)
Sünnieelne kromosoomihaiguste riskihinnang II trimestril (kolme markeriga):-:Pt:S/P:-:
fr-BEFrench (Belgium)
Triple dépistage maternel trimestre II:-:Temps ponctuel:Sérum/Plasma:-:
fr-CAFrench (Canada)
Triple dépistage maternel du deuxième trimestre:-:Temps ponctuel:Sérum/Plasma:-:
fr-FRFrench (France)
Dépistage maternel au cours du 2nd trimestre grossesse triplet panel:-:Ponctuel:Sérum/Plasma:-:
it-ITItalian (Italy)
Secondo trimestre, panel triplo screening materno:-:Pt:Siero/Plasma:-:
pt-BRPortuguese (Brazil)
Triagem do segundo trimestre de maternidade tripla painel:-:Pt:Sor/Plas:-:
ru-RURussian (Russian Federation)
Второй триместр трипл мать скрин панель:-:ТчкВрм:Сыв/Плаз:-:
es-ARSpanish (Argentina)
detección selectiva de marcadores triples:-:punto en el tiempo:suero/plasma:-:
es-ESSpanish (Spain)
Panel triple screning materno del segundo trimestre:Propiedades mixtas (sólo paneles):Punto temporal:Suero o Plasma:-:

LOINC FHIR® API Example - CodeSystem and Questionnaire Requests Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=35086-8 https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/35086-8